A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration is a paper indexed in PICO Portal from OpenAlex.
How many citations does A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration have?
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration has 106 citations in the OpenAlex counts PICO Portal stores.
When was A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration published?
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration has 2021 year in the PICO Portal index.
What is the open-access status of A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration?
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration has gold oa status in the PICO Portal index.
What is the DOI of A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration?
The DOI for A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration is on the source record.
What is the PMID of A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration?
The PMID for A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration is on the source record.
What is the OpenAlex record for A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration?
The OpenAlex for A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration is on the source record.